Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01700816 · ClinicalTrials.gov registry record · NA
Prevention of Delirium After Bone Marrow Transplantation
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT01700816: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT01700816 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01700816, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if using bright light sessions during bone marrow transplant can prevent people from developing confusion also known as delirium.
Interventions
- DEVICE Bright light therapy
- DEVICE Sham light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01700816
The ClinicalTrials.gov registry entry for NCT01700816 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bright light therapy is the first listed.
NCT01700816 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01700816 about?
NCT01700816 is a clinical study titled "Prevention of Delirium After Bone Marrow Transplantation". The purpose of this study is to find out if using bright light sessions during bone marrow transplant can prevent people from developing confusion also known as delirium.
What is the current status of trial NCT01700816?
This trial is currently terminated. It is a NA study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2013-10.
What interventions are being tested in trial NCT01700816?
The interventions under investigation include: Bright light therapy (DEVICE), Sham light (DEVICE).
Who is sponsoring clinical trial NCT01700816?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.